Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of February 01 - 06, 2021
Alerts this week cover papers from JCO, Lancet Oncology, Nature Communications, JAMA and Cancer Discovery.
Dr Morgan also highlights the new guidelines for neoadjuvant chemotherapy, endocrine therapy and targeted therapies for breast cancer and also the FDA approval of tepotinib for NSCLC.
You can watch Dr Morgan's previous roundup here.
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer